Real World Data as Trial End Points
نویسندگان
چکیده
منابع مشابه
Improving Realism in Clinical Trial Simulations via Real‐World Data
Simulation validity depends on how well sampling distributions used reflect real-patient characteristics, such as drug adherence, disease progression, and pharmacologic handling in the body. We challenge the current use of growth charts from nondisease-specific pediatrics in simulations for drug development. Complementary use of data from clinical trials and the real-world is expected to achiev...
متن کاملModeling Real-World Data Sets
Traditionally, the performance of algorithms is evaluated using worst-case analysis. For a number of problems, this type of analysis gives overly pessimistic results: Worst-case inputs are rather artificial and do not occur in practical applications. In this lecture we review some alternative analysis approaches leading to more realistic and robust performance evaluations. Specifically, we focu...
متن کاملMeasuring Real-World Data Availability
This paper examines how server marketing claims of high reliability (e.g., 99.999%) stack up against real world data measurements. Our goals were to: measure discretionary NFS data availability, compare data availability between standalone and clustered systems, and draw some conclusions about best practices for customers. We explain our methodology for measuring, filtering, and categorizing av...
متن کاملRivaroxaban Excels in ‘Real-World’ Trial
Survivors of acute lung injury are likely to experience depression and physical impairment for up to 2 years after leaving the intensive care unit. In a prospective study, 40% of patients had new-onset depression and 66% had new physical impairment after discharge. The findings seem inextricably linked on both psychological and physiological levels, Dr. Oscar J. Bienvenu and his colleagues wrot...
متن کاملValidation of novel imaging methodologies for use as cancer clinical trial end-points.
The success or failure of a clinical trial, of any phase, depends critically on the choice of an appropriate primary end-point. In the setting of phases II and III cancer clinical trials, imaging end-points have historically, and continue presently to play a major role in determining therapeutic efficacy. The primary goal of this paper is to discuss the validation of imaging-based markers as en...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Circulation
سال: 2020
ISSN: 0009-7322,1524-4539
DOI: 10.1161/circulationaha.120.048019